Charles Sawyers
Charles Sawyers
Charles L. Sawyers is an American oncologist known for his significant contributions to the field of cancer research. He currently serves as the Chair of the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center in New York City.
Early Life and Education[edit | edit source]
Sawyers received his medical degree from Johns Hopkins University School of Medicine and completed his residency in internal medicine at the University of California, San Francisco. He later pursued a fellowship in medical oncology at the Dana-Farber Cancer Institute.
Career[edit | edit source]
Sawyers' research focuses on understanding the molecular mechanisms of cancer and developing targeted therapies. He has made groundbreaking discoveries in the field of prostate cancer and has been instrumental in the development of several cancer drugs.
One of Sawyers' most notable achievements was the identification of the BCR-ABL fusion gene in chronic myeloid leukemia, which led to the development of the drug imatinib (Gleevec), a targeted therapy that revolutionized the treatment of this disease.
Sawyers has received numerous awards and honors for his work, including election to the National Academy of Sciences and the National Academy of Medicine.
Research Contributions[edit | edit source]
Sawyers' research has significantly advanced our understanding of cancer biology and has led to the development of novel targeted therapies for various types of cancer. His work has had a profound impact on the field of oncology and has improved the outcomes for many cancer patients.
Personal Life[edit | edit source]
Outside of his research, Sawyers is known for his dedication to mentoring young scientists and clinicians. He is also actively involved in various professional organizations and serves on the editorial boards of several scientific journals.
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
